| 000 | 00990 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513115228.0 | ||
| 264 | 0 | _c19970521 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0741-5400 | ||
| 024 | 7 |
_a10.1002/jlb.61.5.567 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGresser, I | |
| 245 | 0 | 0 |
_aWherefore interferon? _h[electronic resource] |
| 260 |
_bJournal of leukocyte biology _cMay 1997 |
||
| 300 |
_a567-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xpharmacology |
| 650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
| 650 | 0 | 4 |
_aInterferon-beta _xpharmacology |
| 650 | 0 | 4 |
_aInterferons _xpharmacology |
| 773 | 0 |
_tJournal of leukocyte biology _gvol. 61 _gno. 5 _gp. 567-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jlb.61.5.567 _zAvailable from publisher's website |
| 999 |
_c9110724 _d9110724 |
||